A single subcutaneous dose of eprinomectin (Eprecis®) is effective against common gastrointestinal nematodes and lungworms in experimentally infected lactating goats

Parasit Vectors. 2024 May 10;17(1):211. doi: 10.1186/s13071-024-06301-w.

Abstract

Background: The health and productivity of dairy goats continue to be impacted by gastrointestinal nematodes (GIN) and lungworms (LW). Eprinomectin (EPN) is frequently selected for treatment because it is generally effective and does not require a milk withdrawal period. However, some factors, such as lactation, can have an impact on EPN pharmacokinetics and potentially its efficacy. To evaluate whether this can alter the efficacy of Eprecis® 2%, an eprinomectin injectable solution, a study was performed in lactating goats using the dose currently registered in cattle, sheep and goats (0.2 mg/kg).

Methods: This study was a blinded, randomized, controlled trial performed according to the VICH guidelines. Eighteen (18) worm-free lactating goats were included and experimentally challenged on day 28 with a mixed culture of infective gastrointestinal and lung nematode larvae (Haemonchus contortus, Trichostrongylus colubriformis, Teladorsagia circumcincta, Dictyocaulus filaria). At D-1, fecal samples were collected to confirm patent infection in all animals. On D0, the goats were randomly allocated into two groups of nine goats; group 1 was treated with Eprecis® 2% at 0.2 mg/kg BW by subcutaneous injection, while group 2 remained untreated. Fecal samples for egg counts were collected from all animals on days 3, 5, 7, 9, 11 and 14. On D14, all goats were killed, and the abomasum, small intestine and lungs were removed, processed and subsampled to record the number and species of worms.

Results: The treatment was well tolerated. After treatment, the arithmetic mean FEC decreased in the treated group and remained < 5 EPG until the end of the study, while the arithmetic mean FEC in the control group remained > 849.0 EPG. At D14, goats in the treated group had very limited or zero total worm counts, whereas all animals from the control group had a high worm burden. The measured efficacy was 100.0% against H. contortus and T. colubriformis, 99.9% against T. circumcincta and 98.0% against D. filaria.

Conclusions: Eprinomectin (Eprecis®, 20 mg/ml), administered at the label dose (0.2 mg/kg), is highly effective against gastrointestinal nematodes and lungworms in lactating goats.

Keywords: Dictyocaulus filaria; Haemonchus contortus; Teladorsagia circumcincta; Trichostrongylus colubriformis; Controlled trial; Eprinomectin; Gastrointestinal nematodes; Lactating goats; Lungworms; Treatment.

MeSH terms

  • Animals
  • Anthelmintics / administration & dosage
  • Anthelmintics / pharmacokinetics
  • Anthelmintics / therapeutic use
  • Feces* / parasitology
  • Female
  • Gastrointestinal Diseases / drug therapy
  • Gastrointestinal Diseases / parasitology
  • Gastrointestinal Diseases / veterinary
  • Goat Diseases* / drug therapy
  • Goat Diseases* / parasitology
  • Goats*
  • Injections, Subcutaneous / veterinary
  • Ivermectin* / administration & dosage
  • Ivermectin* / analogs & derivatives
  • Ivermectin* / pharmacokinetics
  • Ivermectin* / therapeutic use
  • Lactation* / drug effects
  • Lung / parasitology
  • Nematoda / drug effects
  • Nematode Infections* / drug therapy
  • Nematode Infections* / parasitology
  • Nematode Infections* / veterinary
  • Parasite Egg Count / veterinary

Substances

  • eprinomectin
  • Ivermectin
  • Anthelmintics